NCT00913224View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 1993

Primary Completion Date

April 30, 1993

Study Completion Date

April 30, 1993

Conditions
Inflammation
Interventions
DRUG

Diclofenac Sodium 50 mg Tablets (Geneva Pharmaceuticals, Inc)

DRUG

Voltaren 50 mg Tablets (Geigy Pharmaceuticals)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY